BrainTale Secures 1M€ Seed Round
Summary
Julie Rachline, CEO, comments “This first financing milestone is a leading step towards our journey to enable adapted care for patients with neurological diseases. Created in July 2018, the company’s first CE marked product is brainQuant, a SaaS solution providing brain lesion quantification from diffusion MRI (Magnetic Resonance Imaging). BrainScore-coma, a SaaS solution combining brainQuant and artificial intelligence algorithms for predicting coma emergence of patients in intensive care after severe brain injuries is expected to receive CE marking by mid-2021. Eric Garnier has 35 years of experience in healthcare and medical devices management, acquired in multinational industries (BMS, Danaher) including more than a decade of expatriation in London, Singapore and Boston. Member of the Paris Business Angels network, Julien Vandewalle held managerial positions at international level within leading Medtech and Pharma groups (Medtronic, Edwards, Eli Lilly), and specializes in the commercial launch of connected health products.